Inventor
Richard Lathe
Inventor
Strasbourg, FR
Overview
Patents· 17 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C12Nprimary
C12NMicroorganisms or enzymes30%
A61KPreparations for medical, dental or toiletry purposes19%
C07KPeptides19%
A01KAnimal husbandry13%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations11%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture4%
C07JSteroids2%
Y02ATechnologies for adaptation to climate change2%
PatentTitleYear
7,033,779'Method for preparing steroids modified by yeast fermentation'20067,005,299'Expression of heterologous genes according to a targeted expression profile'20066,420,353'Use of 7 -substituted steroid to treat neuropsychiatric, immune or endocrine disorders'20026,328,956'Pharmaceutical composition for the treatment or prevention of a malignant tumor'20016,207,877'Transgenic coagulation factor XIII defective animal and its use for testing wound healing and bleeding'20016,203,795'Pharmaceutical composition for the treatment or prevention of a malignant tumor'20016,184,350'Hippocampus-associated proteins, DNA sequences coding therefor and uses thereof'20016,150,169'Expression of the heterologous genes according to a targeted expression profile'20006,024,953'Vaccine against rabies and process for preparation thereof'20006,007,806'Expression of a tumor-specific antigen by a recombinant vector virus and use thereof in preventive or curative treatment of the corresponding tumor'19995,976,850'Hippocampus-associated proteins; DNA sequences coding therefor and uses thereof'19995,861,381'Pharmaceutical composition for the treatment of a malignant tumor'19995,830,477'Vaccine against rabies and process for preparation thereof'19985,744,133'Expression of a tumor-specific antigen by a recombinant vector virus and use thereof in preventitive or curative treatment of the corresponding tumor'19985,476,995'Peptide production'19955,366,894'Peptide production'19945,322,775'Peptide production'1994Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1994Patents assigned to PHARMACEUTICAL PROTEINS LTD (2)· patent assignee history
1994–2000Based in Strasbourg, FR· patent location history
1998–2006Patents assigned to TRANSGENE SA (8)· patent assignee history
1999–2002Patents assigned to BTG INT LTD (3)· patent assignee history
1999–2006Based in Edinburgh, GB· patent location history
1999–2001Based in Leeds, GB· patent location history
2000–2006Patents assigned to UNIV EDINBURGH (2)· patent assignee history
2001Patents assigned to AVENTIS BEHRING GMBH (1)· patent assignee history
2006Based in Edinburg, TX, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| TRANSGENE SA | 8 | 1998–2006 |
| BTG INT LTD | 3 | 1999–2002 |
| PHARMACEUTICAL PROTEINS LTD | 2 | 1994 |
| UNIV EDINBURGH | 2 | 2000–2006 |
| AVENTIS BEHRING GMBH | 1 | 2001 |
Locations
| Location | Patents | Span |
|---|---|---|
| Strasbourg, FR | 7 | 1994–2000 |
| Edinburgh, GB | 6 | 1999–2006 |
| Leeds, GB | 3 | 1999–2001 |
| Edinburg, Texas, US | 1 | 2006 |